NCT04984876
Efficacy and Safety of QGE031 (Ligelizumab) in Patients With Peanut Allergy treatment 3 terminated NCT05432388
Study of Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With an Allergy to Peanuts treatment 2 recruiting NCT05741476
Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age No drug interventions treatment 3 active_not_recruiting NCT05695261
Evaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients No drug interventions treatment 2 recruiting NCT03907397
Immune Basis and Clinical Implications of Threshold-based Phenotypes of Peanut Allergy No drug interventions treatment 2 completed NCT05138757
Pinpoint Trial: Prebiotics IN Peanut Oral ImmunoTherapy No drug interventions prevention 1 / 2 active_not_recruiting NCT06297083
Analysing HIgh Dose Probiotic Peanut Oral Immunotherapy (PPOIT) and High Dose Peanut Oral Immunotherapy (OIT) Versus LOw Dose Peanut OIT for Peanut Allergy No drug interventions treatment 2 withdrawn NCT06331728
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IGNX001 No drug interventions treatment 1 recruiting NCT01197053
Epicutaneous Immunotherapy in Peanut Allergy in Children No drug interventions treatment 2 completed NCT01897077
The Safety and Efficacy of a Peanut Immunotherapy Dissolving Film for Peanut Allergy No drug interventions treatment 1 / 2 terminated NCT02851277
A Study to Evaluate Safety, Tolerability and Immune Response in Adults Allergic to Peanut After Receiving Intradermal or Intramuscular Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein DNA Plasmid Vaccine No drug interventions treatment 1 completed NCT03736447
Peanut Oral Immunotherapy Study of Early Intervention for Desensitization No drug interventions treatment 3 completed NCT03936998
VE416 for Treatment of Food Allergy treatment 1 / 2 recruiting NCT04415593
High and Low Dose Oral Peanut Immunotherapy - Comparison of Efficacy and Safety No drug interventions treatment Not Available recruiting NCT00949078
Omalizumab in the Treatment of Peanut Allergy treatment 2 completed NCT02993107
PALISADE Follow-on Study (ARC004) No drug interventions treatment 3 completed NCT02991885
HAL-MPE1 Safety and Tolerability Study No drug interventions treatment 1 completed NCT01781637
Peanut Reactivity Reduced by Oral Tolerance in an Anti-IgE Clinical Trial treatment 1 / 2 completed NCT03859700
Follow-up of the EPITOPE Study to Evaluate Long-term Efficacy and Safety of DBV712 in Young Children No drug interventions treatment 3 enrolling_by_invitation NCT04603300
OMEGA Study: A Study of the Safety and Feasibility of Up-titration With INT301 in Adults With Sensitivity to Peanut No drug interventions treatment 1 completed NCT04974970
Pilot Study on Immunotherapy for the Treatment of Persistant Peanut Allergy No drug interventions treatment 1 / 2 terminated NCT01373242
Sublingual Immunotherapy for Peanut Allergy and Induction of Tolerance treatment 1 / 2 completed NCT01290913
Xolair Enhances Oral Desensitization in Peanut Allergic Patients treatment 1 / 2 completed NCT03755713
A Study to Evaluate Safety, Tolerability and Immune Response in Adolescents Allergic to Peanut After Receiving Intradermal Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein DNA Plasmid Vaccine No drug interventions treatment 1 completed NCT04872218
Adjuvant Treatment With Abatacept to Promote Remission During Peanut Oral Immunotherapy treatment 2 active_not_recruiting NCT04887441
Allergology: Information, Data and Knowledge Organization No drug interventions Not Available Not Available unknown_status NCT05621317
A Safety and Efficacy Study of PVX108 in Children and Adolescents With Peanut Allergy No drug interventions treatment 2 enrolling_by_invitation NCT01987817
Oral Desensitization to Peanut in Peanut-Allergic Children and Adults Using Characterized Peanut Allergen OIT No drug interventions treatment 2 completed NCT03013517
Follow-up of the PEPITES Study to Evaluate Long-term Efficacy and Safety of Viaskin Peanut in Children No drug interventions treatment 3 unknown_status NCT03881696
Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Participants treatment 3 active_not_recruiting NCT04761835
STEP-IT-UP - Peanut Allergy Study for Infants No drug interventions treatment 2 withdrawn NCT02821286
Identification of Anaphylactogenic Antibodies in Peanut Allergy No drug interventions Not Available Not Available enrolling_by_invitation NCT01170286
Safety of Epicutaneous Immunotherapy for the Treatment of Peanut Allergy No drug interventions treatment 1 completed NCT01918657
Walnut Oral Immunotherapy for Tree Nut Allergy No drug interventions treatment Not Available withdrawn NCT03352726
A Study to Assess the Biological Potency of Peanut Allergen Extract in Adolescent and Adult Peanut Allergic Subjects No drug interventions other 1 completed NCT05163574
Induction of Sustained Unresponsiveness to Peanuts Using High- and Low-dose Peanut Oral Immunotherapy No drug interventions treatment Not Available recruiting NCT02960074
Evaluating the Safety and Efficacy of Oral Encapsulated Fecal Microbiota Transplant in Peanut Allergic Patients treatment 1 completed NCT05424731
Expanded Access Protocol of Viaskin® Peanut (DBV712) in Peanut-allergic Children No drug interventions Not Available Not Available available NCT04881773
Oral Low Doses Tolerance INduction Study for Peanuts No drug interventions Not Available Not Available unknown_status NCT03679676
Clinical Study Using Biologics to Improve Multi OIT Outcomes (COMBINE) treatment 2 active_not_recruiting NCT03532360
Peanut and Tree Nut Desensitization No drug interventions treatment Not Available unknown_status NCT02304991
FARE Peanut SLIT and Early Tolerance Induction treatment 2 completed NCT01274429
Peanut Oral Immunotherapy (OIT) - Initial Pilot Study in Adults No drug interventions treatment 1 / 2 terminated NCT05165329
A Randomized, Controlled Trial of Probiotic and Peanut Oral Immunotherapy (PPOIT) in Inducing Tolerance in Hong Kong Children With Peanut Allergy Compared With Oral Immunotherapy (OIT) Alone and With Placebo treatment Not Available active_not_recruiting NCT01324401
Oral Peanut Immunotherapy No drug interventions treatment Not Available completed NCT02916446
Safety Study of Viaskin Peanut to Treat Peanut Allergy No drug interventions treatment 3 completed NCT05667610
Immune-supportive Diet and Gut Permeability in Allergic Children No drug interventions treatment Not Available recruiting NCT01451450
Efficacy and Safety of 4 Doses of QGE031 in Patients 18-50 Years of Age With Peanut Allergy treatment 2 withdrawn NCT03251508
Salvage Peanut Oral Immunotherapy Study No drug interventions treatment 1 / 2 completed NCT05440643
Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy No drug interventions treatment 1 recruiting NCT03201003
ARTEMIS Peanut Allergy In Children No drug interventions treatment 3 completed NCT02198664
Oral Desensitization to Peanut in Peanut Allergic Children and Adults Using CPNA Peanut OIT Safety Follow-On Study No drug interventions treatment 2 completed NCT02920021
Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Peanut Allergy treatment 2 completed NCT03292484
Longer-term Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008) No drug interventions treatment 3 completed NCT01750879
Tolerance Following Peanut Oral Immunotherapy No drug interventions basic_science 1 / 2 completed NCT03849079
Validation of the HYPONUT Product No drug interventions other Not Available terminated NCT01950533
The Utility of Food-Specific IgE Measured With the IMMULITE 2000 Assay to Predict Symptomatic Food Allergy No drug interventions Not Available Not Available completed NCT02698033
High Threshold Peanut Challenge Study No drug interventions Not Available Not Available completed NCT03211247
Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age No drug interventions treatment 3 active_not_recruiting NCT01812798
Canadian Peanut Thresholds Study No drug interventions prevention Not Available unknown_status NCT05476497
Phase I Trial to Evaluate VLP Peanut in Healthy and Peanut Allergic Subjects No drug interventions treatment 1 recruiting NCT02046083
Peanut Oral Induction Tolerance in Peanut's Allergic Teenagers No drug interventions treatment 2 / 3 unknown_status NCT03070561
Evaluating Peanut Immunotherapy Dissolving Film in Healthy Subjects No drug interventions other 0 completed NCT03019328
Early Peanut Introduction: Translation to Clinical Practice No drug interventions Not Available Not Available completed NCT01955109
Follow-up of the VIPES Study to Evaluate Efficacy and Safety of Viaskin Peanut in Adults and Children No drug interventions treatment 2 completed NCT05250856
CNP-201 in Subjects With Peanut Allergy No drug interventions treatment 1 terminated NCT02979600
Clinical and Biological Efficacy of Peanut Oral Immunotherapy No drug interventions Not Available Not Available completed NCT05662800
Development of Peanut, Sesame, and Tree Nut Allergy in Polish Children at High Risk of Food Allergy No drug interventions Not Available Not Available recruiting NCT02103270
The Peanut Oral Immunotherapy Study: Safety, Efficacy and Discovery No drug interventions treatment 2 completed NCT03682770
Study in Pediatric Subjects With Peanut Allergy to Evaluate Efficacy and Safety of Dupilumab as Adjunct to AR101 (Peanut Oral Immunotherapy) treatment 2 completed NCT03337542
AR101 Real-World Open-Label Extension Study No drug interventions treatment 3 completed NCT03852342
Reactive Doses and Times During Oral Food Challenge to Peanut No drug interventions Not Available Not Available completed NCT02636699
Efficacy and Safety of Viaskin Peanut in Children With Immunoglobulin E (IgE)-Mediated Peanut Allergy No drug interventions treatment 3 completed NCT03546413
Follow up of LEAP Participants and Their Families No drug interventions Not Available Not Available completed NCT02163018
HAL-MPE1 First-in-human No drug interventions treatment 1 completed NCT01601522
Peanut Allergy Oral Immunotherapy Desensitization treatment 2 completed NCT02194530
Reduction of Peanut Reactivity and Immune Modulation With Anti-IgE Therapy No drug interventions Not Available Not Available completed NCT03680066
Study to Assess Tolerance of Traces in Peanut/Tree Nut Allergic Children. No drug interventions other Not Available terminated NCT03513965
Allergy Experience Study No drug interventions basic_science Not Available completed NCT03648320
The Grown Up Peanut Immunotherapy Study No drug interventions treatment Not Available completed NCT01675882
Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy No drug interventions treatment 2 completed NCT02402231
Treatment of Severe Peanut Allergy With Xolair (Omalizumab) and Oral Immunotherapy treatment 2 unknown_status NCT04371627
Viaskin® Peanut (DBV712) Expanded Access Protocol No drug interventions Not Available Not Available no_longer_available NCT03126227
Real-World AR101 Market-Supporting Experience Study in Peanut-Allergic Children (RAMSES) No drug interventions treatment 3 completed NCT02635776
Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE) No drug interventions treatment 3 completed NCT04511494
Oral Immunotherapy for Young Children With Peanut Allergy - Small Children OIT No drug interventions treatment Not Available active_not_recruiting NCT04222491
Food Oral Immunotherapy for Peanut Allergy No drug interventions treatment 2 enrolling_by_invitation NCT03703791
Real World, Open Label, QOL Assessment of Peanut Immunotherapy AR101 in Children and Adolescents No drug interventions treatment 3 terminated NCT04163562
Oral Immunotherapy for Peanut Allergic Patients No drug interventions treatment 1 / 2 unknown_status NCT01074840
Understanding How the Immune System Responds to Viruses in Peanut Allergic Children Undergoing Peanut Oral Immunotherapy No drug interventions treatment Not Available completed NCT04950504
Evaluate the Safety, Tolerability, Pharmacodynamics, and Efficacy of CNP-201 in Subjects Ages 16-35 With Peanut Allergy No drug interventions treatment 1 terminated NCT01259804
Study of Tolerance to Oral Peanut No drug interventions treatment 1 completed NCT06256146
Investigating Modified Protocols of Oral Immunotherapy to Validate Efficacy and Safety No drug interventions treatment Not Available recruiting NCT05503446
Using Commonly Available Food Products To Treat Food Allergy No drug interventions treatment Not Available recruiting NCT01489514
Evaluation of Allergenicity of Hypoallergenic Peanut Product in Peanut Allergic Subjects No drug interventions Not Available Not Available completed NCT03793608
Study to Evaluate Dupilumab Monotherapy in Pediatric Patients With Peanut Allergy treatment 2 completed NCT02966938
Visual Recognition of Allergens by Allergic Patients and/or Their Parents No drug interventions Not Available Not Available completed NCT02745418
The Role of Filaggrin Mutations and Sensitization Pathways in Allergic Rhinitis and Peanut Allergy No drug interventions Not Available Not Available active_not_recruiting NCT02192866
Blood Samples for the Study of Peanut, Tree Nut and Other Food Allergies No drug interventions Not Available Not Available recruiting